Vaxcyte Inc. (PCVX)

NASDAQ: PCVX · Real-Time Price · USD

35.32

-0.52 (-1.45%)

At close: May 01, 2025, 3:59 PM

35.60

0.79%

Pre-market: May 02, 2025, 05:27 AM EDT

Vaxcyte Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	387.88M	397.45M	834.66M	68.98M	386.2M	58.98M	66.09M	36.14M
Short-Term Investments	1.36B	682.78M	96.72M	176.99M	n/a	n/a	n/a	n/a
Long-Term Investments	1.39B	162.68M	26.55M	27.12M	n/a	n/a	n/a	n/a
Other Long-Term Assets	65.68M	38.66M	5.43M	4.96M	550K	584K	723K	311K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-1M	-1.2M	-300K	-200K	n/a	n/a
Other Current Assets	40.78M	9.57M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.79B	1.1B	942.55M	256.35M	389M	61.72M	66.67M	36.35M
Property-Plant & Equipment	270.15M	110.62M	31.65M	35.91M	3.27M	3.39M	3.41M	2.97M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.72B	311.96M	63.62M	67.99M	3.82M	3.98M	4.13M	3.28M
Total Assets	3.51B	1.41B	1.01B	324.34M	392.83M	65.7M	70.8M	39.63M
Account Payables	48.45M	14.59M	9.79M	6.76M	29.79M	3.38M	2.83M	1.81M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-297K	n/a
Short-Term Debt	n/a	n/a	5.91M	5.28M	n/a	n/a	n/a	n/a
Other Current Liabilities	26.45M	11.06M	17.73M	7.95M	16.79M	7.1M	2.4M	850K
Total Current Liabilities	140.18M	145.34M	40.52M	28.72M	46.86M	11.05M	6.71M	4.26M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.76M
Other Long-Term Liabilities	65.32M	n/a	9K	96K	122K	161.02M	121.66M	212K
Total Long-Term Liabilities	65.32M	22.11M	12.04M	11.6M	122K	161.02M	121.82M	4.43M
Total Liabilities	205.5M	167.45M	52.56M	40.32M	46.98M	172.07M	128.53M	8.69M
Total Debt	71.11M	29.22M	17.94M	16.78M	n/a	161K	458K	4.22M
Common Stock	128K	98K	82K	56K	54K	7K	6K	6K
Retained Earnings	-1.39B	-924.39M	-522.13M	-298.64M	-198.56M	-109.35M	-59.07M	-29.59M
Comprehensive Income	-3.87M	179K	-361K	-241K	-392.83M	-160.31M	-1.75M	n/a
Shareholders Equity	3.31B	1.24B	953.61M	284.02M	345.84M	-106.37M	-57.73M	30.94M
Total Investments	2.75B	845.45M	123.27M	204.1M	n/a	n/a	n/a	n/a